9 Meeting the Growing Demand for GLP-1 Medications Despite these issues, we see the potential for long-term, durable demand for GLP-1s and similar medications, even if there are zig-zags along the way
View Our Interactive Dashboard on GLP-1RA Therapies in Development (Free Excel Available) Our view With the rise in urbanization, affluence and sedentary lifestyles, the incidence of diabetes, heart and liver diseases and obesity is increasing
Both are injectable medications used to manage T2DM, but they belong to different classes 2 , 5 : -Ozempic is a brand name for the drug semaglutide, which is a GLP-1 receptor agonist that activates one hormone pathway
Also, will Novo Nordisk allow there to be a pricing parity between these products (privately scripted) so as not to further hinder people with chronic weight management issues getting the support they need? Dr South said it was good to have another treatment option for the complex chronic condition of obesity but that it raised questions for both obesity and diabetes patients
Whether retatrutide can match it in TRIUMPH-2 remains to be seen